lungs Related Content

Elize Sturkenboom – van de Wetering, Venture Leader of Lung Oncology at Phillips Healthcare, discusses the diagnosis and treatment of lung cancer through new minimally invasive therapy.

Prashant Warier, CEO and Founder, Qure.ai, explains beating lung cancer with the AI edge.

Researchers have created a way to detect cystic fibrosis infection in minutes - beating the current wait time of days.

Dr Michel Gasana & Dr Hugues Lago from WHO - Regional Office for Africa, spoke to OAG about the status of tuberculosis prevention

Scientists suggest taking breaks when binge-watching TV to avoid blood clots - with four hour sessions increasing the likelihood by 35%.

Researchers from the University of Leeds have discovered that soot in the atmosphere around Bonfire Night is 100 times its normal level.

Sarah MacFadyen, Vice Chair of the Taskforce for Lung Health and Head of Policy and External Affairs at Asthma UK and the British Lung Foundation, says it’s time that tobacco dependency was treated just like any other illness.

A new study has found that one-third of COVID-19 patients discharged from hospital still present lung changes one year on.

Research led by investigators at Massachusetts General Hospital reveals that people who use both e-cigarettes and tobacco cigarettes are more likely to develop respiratory symptoms compared to those using either one alone.

A new national study, funded by UK Research and Innovation (UKRI), will investigate the long-term effects of COVID-19 lung damage.

Sarah Woolnough, Chief Executive of Asthma UK and the British Lung Foundation, discusses the UK’s toxic air crisis, the invisible threat of air pollution, and outlines how policymakers must protect people’s health and create a fairer, healthier society.

According to data collected by 400 healthcare professionals at the worst moment of the US outbreak, the life support machine that acts in place of the heart and lungs is crucial to reducing COVID-19 deaths for the critically ill.

UK Research and Innovation (UKRI) has awarded £3.5 million-worth of funding to help ground-breaking medical research find new ways to diagnose lung cancer earlier.

Steve Jones, President of EU-IPFF and Chair, Action for Pulmonary Fibrosis in the UK describes the connection between COVID-19 and pulmonary fibrosis.

Zak Bond, Policy Officer at the British Lung Foundation, explores why the government must commit to stronger air pollution targets to protect our lungs as we recover from COVID-19.

Michael Roth discusses soluble circulating cytokine receptors in chronic inflammatory lung diseases, which he describes as the under-estimated regulators of inflammation and remodelling.

Jessica Eagelton, co-chair of the Taskforce for lung Health Pulmonary Rehabilitation working group, discusses Pulmonary rehabilitation: a drug-free treatment that is changing the lives of people with lung disease.

According to Maximilian Kunisch and Giuseppe De Carlo from the European Federation of Allergies and Airways Diseases Patients' Associations, respiratory patients in Europe need to set the research priorities for asthma and chronic obstructive pulmonary disease (COPD).

Dr Fred A. Wagshul, Pulmonologist and Medical Director at the Lung Center of America explains why he supports the addition of asthma medications to the exemption list in the UK.

Paul Riddick, Co-Founder and Technical Director at Vodex explores how contaminates being produced on a daily basis in the workplace can damage your health and could even prove fatal.